共 50 条
- [43] Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program SALUD PUBLICA DE MEXICO, 2016, 58 (01): : 71 - 83
- [44] Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (04): : 724 - 731
- [48] Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study LANCET INFECTIOUS DISEASES, 2017, 17 (06): : 615 - 625
- [49] EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF TETRAVAX-DV, A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 248 - 248
- [50] Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (03): : 426 - 433